Document 1180 DOCN M94A1180 TI Immunoglobulin E (IgE) levels in different risk groups. DT 9412 AU Carcamo C; Miguez MJ; Shor-Posner G; Lu Y; Quesada J; Page BJ; Fletcher MA; Baum MK; Department of Epidemiology and Immunology, University of Miami; School of Medicine, FL. SO Int Conf AIDS. 1994 Aug 7-12;10(2):190 (abstract no. PB0775). Unique Identifier : AIDSLINE ICA10/94371395 AB OBJECTIVE: IgE levels, which appear to have an important role in immunohomeostasis, were determined in asymptomatic HIV+ (n = 21) and HIV- (n = 17) intravenous drug users (IDUs), in relationship to immune function and nutritional status, and compared to measurements obtained in asymptomatic HIV+ (n = 20) and HIV- (n = 25) homosexual men. METHODS: IgE levels were assessed with the Microplate Total IgE, a two-site immunoradiometric technique, supplied by Kallestad. Lymphocyte surface markers (CD4 and CD8) were determined by flow cytometry, using two color direct immunofluorescence with monoclonal antibodies (Coulter Immunology Miami, FL). Total plasma vitamin E was determined by high performance liquid chromatography. RESULTS: Stepwise regression analysis revealed that the level of IgE was significantly associated with HIV-1 status (p = 0.0009), intravenous drug use (p = 0.014), plasma level of vitamin E (p = 0.006), and CD8 cell count (p = 0.0001). HIV+ IDUs exhibited significantly higher IgE levels (444.3 +/- 352.4) than HIV-1 + homosexual men (186.4 +/- 251.3, p < 0.01), with similar CD4 cell counts. Plasma levels of vitamin E were significantly diminished in HIV+ IDUs (5.1 +/- 1.7 micrograms/ml), and HIV-IDUs (5.4 +/- 1.9), relative to the seropositive and seronegative homosexual men (9.1 +/- 6.0, p < 0.0001) and (10.2 +/- 5.1, p < 0.002), respectively. DISCUSSION AND CONCLUSIONS: Intravenous drug use and vitamin E status appear to strongly influence plasma levels of IgE. The significant association between IgE and HIV-1 status and CD8 cell count, suggests that IgE levels may be a useful marker to monitor HIV-1 disease in different risk groups. DE Biological Markers/BLOOD Comparative Study *Homosexuality Human HIV Seronegativity/IMMUNOLOGY HIV Seropositivity/BLOOD/*IMMUNOLOGY IgE/*BLOOD Leukocyte Count Male Regression Analysis Risk Factors *Risk-Taking Substance Abuse, Intravenous/BLOOD/*IMMUNOLOGY T-Lymphocytes MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).